You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Skip to content
Contact us
Emergency information
Print Page
Increase Font Size
Decrease Font Size
Menu
NSW Health
Search Keywords
Search
Menu
COVID-19
COVID-19 in NSW
NSW Government - COVID-19
Guidelines and fact sheets
Statistics and surveillance
Information for people with disability
COVID-19 vaccination in NSW
Information for the NSW community
Information for community pharmacists
Information for NSW Health immunisation providers
Public
Helpful information
Find information by health topic
Find a hospital / health service
Emergency department waiting times
Patient care
LGBTIQ+ health
Mental health
Aboriginal health
Aged care
Disability
Transport for health
Children and families
Kids and families
Pregnancy options
Assisted reproductive technology
Save the date to vaccinate
Violence, abuse and neglect
Healthy living
Awareness and prevention
Immunisation
Oral health
Emergency preparedness
Sexual health
Ending HIV
Community sharps management
Improving your health
Healthy eating active living
Quitting smoking
Environmental health
Hepatitis B and C
Women's health
Your Room - Information about alcohol and other drugs
Professionals
For general practitioners
Infectious diseases
Immunisation
Tobacco and smoking cessation
Control guidelines
Disease notification
Child weight management resources
For health professionals
Alcohol and other drugs
Outpatient referral criteria
Nursing and midwifery
Pharmaceuticals
Private health facilities
Public health legislation
Preconception, maternity, and child and family health
Interpreting/translating and multicultural health services
Clinical ethics
Research
Open data
Search open data site
Search via topics
Medical research
NSW Health and Medical Research
Healthcare innovation portal
New health technologies
Human tissue
Population health
Epidemiology and evidence
NSW population health surveys
HealthStats NSW
Careers
For jobseekers
Search for a job
Recruitment initiatives
Training programs
Aboriginal workforce - Stepping Up
Imagine Rural
For students
Scholarships and training programs
Clinical placements
Map My Health Career
Workforce and employment
Workforce planning and culture
Remuneration and conditions
Recruitment and employment policies
Human resources - e-compendium
Medical career planning
Senior executives
Publications
Publications and resources
Fact sheets
Publications
Multilingual resources
Reports
Safety alerts
RSS feeds
Policies and procedures
Policy and procedure manuals
Policy directives, guidelines and information bulletins
Media
Media releases
NSW Health
The Hon. Ryan Park, MP
The Hon. Rose Jackson, MLC
The Hon. David Harris, MP
Social media
X (formerly Twitter)
Facebook
LinkedIn
YouTube
Instagram
TikTok
About
NSW Health
Our structure
Our organisation chart
Local health districts
Government priorities
Value based healthcare
Climate risk and net zero
Regional health
Diversity Inclusion Belonging
Engaging with NSW Health
History of medical administration in NSW
Ministry of Health
Our structure
Our organisation chart
Our people
Working at the Ministry of Health
Government Information Public Access Act (GIPA)
Contact us
Ministers
The Hon. Ryan Park, MP
Profile
Media releases
The Hon. Rose Jackson, MLC
Profile
Media releases
The Hon. David Harris, MP
Profile
Media releases
Home
Population health research and evaluation
The Kirby Institute case study
Population health research and evaluation
Currently selected
What is population health research?
Population Health Research Strategy
Research and evaluation guides
Prevention Research Support Program
The Kirby Institute case study
Content 1
Modelling the epidemiology of STIs in the gay and bisexual population of NSW in the era of PrEP
Rates of sexually transmitted infections (STI) among Gay and Bisexual Men (GBM) have been rising steadily in recent years.
1,2
This is thought to be due, at least in part, to increases in condom-less sex in this population. This decline in consistent condom use is unsurprising given the reduced threat of HIV due to antiretroviral therapy and the increasing uptake of Pre-Exposure Prophylaxis (PrEP).
3
This last factor is particularly pertinent with the recent addition of PrEP to the Australian Pharmaceutical Benefits Scheme. Conversely, regular testing for STIs has become more common in recent years.
4
This is important because infections are frequently asymptomatic, allowing sexually active individuals to infect multiple partners without being aware of their own infection status. The aim of this PRSP-funded work is to explore the impact that expanding uptake of PrEP is likely to have on STI incidence and prevalence among gay and bisexual men in NSW.
The dynamics of STI epidemiology are complex, multi-factorial, and are often best studied by computer simulations calibrated to real-world data. We have built an agent-based model to simulate STI epidemiology in Sydney’s GBM population. Such models are well-suited to incorporate the large variation in relevant parameters at the individual level. Currently our model only considers the transmission of gonorrhoea and accounts for sexual behaviour, HIV status, PrEP use, and STI testing frequency. The model has been constructed, however, to facilitate the inclusion of other STIs (e.g. chlamydia, syphilis and Mycoplasma genitalium) in due course. The model is also anatomical site-specific, meaning that the infection status of individuals also includes the relevant anatomical sites of infection (rectum, pharynx, urethra). This is important because the various modes of transmission (anal sex, oral sex, etc.) have different transmission probabilities and their involvement in sexual contacts occur with differing frequencies. Furthermore, the use of condoms is only applicable to sexual contacts in which the penis is involved. The current gonorrhoea model is calibrated to trends in gonorrhoea notifications both prior to and following the introduction of PrEP, and makes use of data on testing rates, gonorrhoea diagnoses and sexual behaviour in the PrEP era from the EPIC-NSW PrEP trial
5
that was funded by the NSW government. The model will be used to predict the trajectory of gonorrhoea incidence (and later, other STIs) with the expanding uptake of PrEP, and will evaluate a range of scenarios around testing and changing sexual practices.
A working group has been formed including stakeholders from GBM advocacy groups such as the Australian Federation of AIDS Organisations, as well as representatives from the NSW Ministry of Health and experts from within the Kirby Institute. Our model has the capacity to examine counterfactual scenarios and test hypotheses for which clinical trials are not suitable. Hence questions of relevance to government policy, such as the frequency with which GBM should be tested for STIs, may be addressed and guidelines proposed. It has also been agreed that capability development in modelling, including the interpretation and use of models, will be provided to staff at NSW Health through annual workshops.
Translation into policy and practice will be through the submission of reports to relevant stakeholders, the publication of academic papers, as well as presentations at seminars and conferences. To further enable translation into action, our model is open-source with code readily available for download from a public repository (GitHub
6
), in accordance with emerging publication standards. The work has already leveraged additional research funding from the SPHERE (Sydney Partnership for Health, Education, Research and Enterprise) seed grant scheme
7
for a project in which modelling is being used to evaluate the utility of a range of surveillance and contact tracing strategies in mitigating the emergence and spread of extensively drug resistant gonorrhoea in NSW.
References
Callander D, Guy R, Fairley CK, McManus H, Prestage G, Chow EPF, et al. Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay and bisexual men attending Australian sexual health clinics.
Sex Health
2018; in press.
Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2018
Holt M, Murphy DA. Individual versus community-level risk compensation following pre-exposure prophylaxis of HIV.
Am J Public Health
2017; 107(10): 1568-71.
Gay Community Periodic Surveys
EPIC-NSW Study
Individual-based, site-specific simulator of STI transmission
The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE)
Content 2
Current as at: Wednesday 2 June 2021
Contact page owner:
Centre for Epidemiology and Evidence